WASHINGTON, May 26, 2011 /PRNewswire/ -- Researchers at Harvard University, Brigham and Women's
In addition to reviewing results to date, the research team leaders urged regulators and legislators to renew their focus on making sure people take their medications as directed by their physicians as a way to improve the quality of care and reduce costs for caring for the chronically ill. Annual excess health care costs due to medication non-adherence in the U.S. have been estimated to be as much as $300 billion annually.
"When we began, we knew our research would expand the science of pharmacy care," said Troyen A. Brennan, MD, MPH executive vice president and chief medical officer of CVS Caremark, who heads the research initiative. "The more we studied the topic, the more we realized that there are steps our industry can take today to improve the rates at which people take their medicines. This is important work because we know if we can improve medication adherence rates, we have a unique opportunity to improve the quality and lower the cost of health care."
"Not surprisingly, we learned there is no single answer to solving the puzzle of adherence, even though this problem has been recognized for decades. But there are practices we can improve upon and programs we can implement that can have an impact. That work can start today," said William H. Shrank, MD, MSHS, who heads the research project for Brigham and Women's Hospital and Harvard Medical School.
Among the recommendations called for by the research team are:
In addition, there are policy initiatives the industry and Congress can promote to make sure people are aware of the importance of taking their medicines the right way. Those proposals include:
A webcast of "Advancing Adherence and the Science of Pharmacy Care," a forum held today at the National Press Club, is available at www.cvscaremarkfyi.com/adherence.
About CVS Caremark
CVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of approximately 65,000 pharmacies, including more than 7,200 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com/.
Media Contact:Jon SandbergCVS Caremark(401)770 firstname.lastname@example.org
SOURCE CVS Caremark
Subscribe to our Free Newsletters!
Craniosynostosis is a condition where the bones of the skull are fused together prematurely ...
Episiotomy is a surgical incision made in the perineum between the vaginal orifice and the anus ...
Stickler syndrome is a rare genetic disorder which causes multisystem disorders predominantly ...View All